NUDT9P1: A Drug Target / Disease Biomarker (G119369)
NUDT9P1: A Drug Target / Disease Biomarker
NUDT9P1, also known as NUDT9, is a protein that is expressed in various tissues throughout the body. It is a key regulator of theNotch signaling pathway, which is involved in cell-to-cell and cell-to-environmental signaling. NUDT9P1 has been identified as a potential drug target and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The Notch signaling pathway is a critical pathway that regulates the development and maintenance of tissues and organs. It is involved in the regulation of stem cell proliferation, differentiation, and plasticity, as well as the regulation of neural circuit formation and function. The Notch signaling pathway is also involved in the regulation of immune cell function, and has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
NUDT9P1 is a key regulator of the Notch signaling pathway. It is a 21-kDa protein that is expressed in various tissues throughout the body, including the brain, spinal cord, heart, and kidneys. NUDT9P1 is a G protein-coupled receptor (GPCR), which means that it is involved in the regulation of gene expression by the action of intracellular signaling molecules, such as growth factors.
NUDT9P1 is involved in the regulation of stem cell proliferation and differentiation. Stem cells are a diverse set of cells that have the ability to develop into any type of cell in the body. NUDT9P1 is required for the regulation of stem cell proliferation and differentiation, and is shown to play a role in the regulation of neural stem cell (NSC) self-renewal and plasticity.
NUDT9P1 is also involved in the regulation of neural circuit formation and function. The Notch signaling pathway is involved in the regulation of neural circuit formation and function, and NUDT9P1 is shown to play a role in this regulation. NUDT9P1 is involved in the regulation of the expression of genes that are involved in neural circuit formation and function, and is shown to play a role in the regulation of neural circuits in the brain.
NUDT9P1 is also involved in the regulation of immune cell function. The Notch signaling pathway is involved in the regulation of immune cell function, and NUDT9P1 is shown to play a role in this regulation. NUDT9P1 is involved in the regulation of the expression of genes that are involved in immune cell function, and is shown to play a role in the regulation of immune cell function in the body.
In addition to its role in the Notch signaling pathway, NUDT9P1 has also been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, NUDT9P1 has been shown to play a role in the regulation of cancer cell growth and survival, and is often used as a potential drug target for cancer. NUDT9P1 has also been shown to play a role in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and is often used as a potential drug target for these diseases.
In conclusion, NUDT9P1 is a protein that is involved in the regulation of the Notch signaling pathway. It is a key regulator of stem cell proliferation and differentiation, neural circuit formation and function, and immune cell function. NUDT9P1 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, NUDT9P1 is an attractive potential drug target for a variety of diseases.
Protein Name: Nudix Hydrolase 9 Pseudogene 1
The "NUDT9P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NUDT9P1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NUF2 | NUFIP1 | NUFIP2 | NUGGC | NUMA1 | NUMB | NUMBL | NUP107 | Nup107-160 complex | NUP133 | NUP153 | NUP155 | NUP160 | NUP188 | NUP205 | NUP210 | NUP210L | NUP210P1 | NUP210P2 | NUP214 | NUP35 | NUP37 | NUP42 | NUP43 | NUP50 | NUP50-DT | NUP54 | NUP58 | NUP62 | NUP62CL | NUP85 | NUP88 | NUP93 | NUP98 | NUPR1 | NUPR2 | NUS1 | NUS1P1 | NUS1P3 | NUSAP1 | NUTF2 | NUTF2P4 | NUTM1 | NUTM2A | NUTM2A-AS1 | NUTM2B | NUTM2B-AS1 | NUTM2D | NUTM2E | NUTM2F | NUTM2G | NVL | NWD1 | NWD2 | NXF1 | NXF2 | NXF3 | NXF4 | NXF5 | NXN | NXNL1 | NXNL2 | NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1
